Sugi Predict

Sugi Predict / Compounds / SCHEMBL6045571

SCHEMBL6045571

SCHEMBL6045571

CCC(=O)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 8/20 1.00
▸ SIGMAR1 Q99720 2/20 1.00
▸ CHRM3 P20309 8/20 0.79
▸ CHRM2 P08172 7/20 0.79
▸ SLC22A1 O15245 1/20 0.77
▸ NR1I2 O75469 1/20 0.77
▸ ABCB1 P08183 1/20 0.77
▸ CHRM1 P11229 1/20 0.77
▸ DRD2 P14416 1/20 0.77
▸ ADRA2B P18089 1/20 0.77
▸ ADRA2C P18825 1/20 0.77
▸ MAOA P21397 1/20 0.77
▸ DRD4 P21917 1/20 0.77
▸ MAOB P27338 1/20 0.77
▸ ADRA1A P35348 1/20 0.77
▸ HRH1 P35367 1/20 0.77
▸ ADRA1B P35368 1/20 0.77
▸ DRD3 P35462 1/20 0.77
▸ OPRD1 P41143 1/20 0.77
▸ OPRK1 P41145 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29651340 0.99 OPRM1 (0.97) OPRM1SIGMAR1CHRM3CHRM2SLC22A1
Oxalic Acid SCHEMBL6045624 0.97 OPRM1 (0.95) OPRM1SIGMAR1CHRM3CHRM2SLC22A1
SCHEMBL925917 0.93 OPRM1 (0.86) OPRM1SIGMAR1CHRM3CHRM2SLC22A1
SCHEMBL15920014 0.93 OPRM1 (0.86) OPRM1SIGMAR1CHRM3CHRM2SLC22A1
SCHEMBL15920012 0.93 OPRM1 (0.86) OPRM1SIGMAR1CHRM3CHRM2SLC22A1
SCHEMBL11577007 0.92 OPRM1 (0.86) OPRM1SIGMAR1CHRM3CHRM2SLC22A1
SCHEMBL15920011 0.92 OPRM1 (0.84) OPRM1SIGMAR1CHRM3CHRM2SLC22A1
SCHEMBL15920013 0.90 OPRM1 (0.80) OPRM1SIGMAR1CHRM3CHRM2SLC22A1
SCHEMBL23805130 0.89 OPRM1 (0.79) OPRM1SIGMAR1CHRM3CHRM2SLC22A1
SCHEMBL15920038 0.89 OPRM1 (0.79) OPRM1SIGMAR1CHRM3CHRM2SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12529695-B2 Fentanyl analogue detection methods and kits thereof VERITEQUE USA, INC. (US) 2026-01-20 — — US disclosed
US-20250314593-A1 DEVICES, METHODS AND KITS FOR DETECTING EXPLOSIVES AND ILLICIT DRUG SUBSTANCES TRACE EYE-D, LLC 2025-10-09 — — US disclosed
US-20230349935-A1 IN-FIELD COLOUR TEST FOR SCREENING FENTANYL AND ANALOGUES THEREOF UNIVERSITY OF TECHNOLOGY SYDNEY (AU) 2023-11-02 — — US disclosed
US-20230349935-A1 IN-FIELD COLOUR TEST FOR SCREENING FENTANYL AND ANALOGUES THEREOF UNIVERSITY OF TECHNOLOGY SYDNEY (AU) 2023-11-02 — — US disclosed
US-20230349869-A1 METHODS AND SYSTEMS FOR OPIOID DETECTION NAT TECH & ENG SOLUTIONS SANDIA LLC (US) 2023-11-02 — — US disclosed
US-11733217-B1 Methods and systems for opioid detection NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) 2023-08-22 — — US disclosed
US-20220390439-A1 FENTANYL ANALOGUE DETECTION METHODS AND KITS THEREOF VERITEQUE USA, INC. 2022-12-08 — — US disclosed
US-20220152628-A1 MAGNETIC LEVITATION SYSTEM PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2022-05-19 — — US disclosed
WO-2021184082-A1 IN-FIELD COLOUR TEST FOR SCREENING FENTANYL AND ANALOGUES THEREOF UNIVERSITY OF TECHNOLOGY SYDNEY (AU) 2021-09-23 — — WO disclosed
US-20210093557-A1 NASAL DRUG PRODUCTS AND METHODS OF THEIR USE ADAPT PHARMA LTD (IE) 2021-04-01 — — US disclosed
WO-2020190845-A1 MAGNETIC LEVITATION SYSTEM PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2020-09-24 — — WO disclosed
US-20200030229-A1 NASAL DRUG PRODUCTS AND METHODS OF THEIR USE Adapt Pharma Limited 2020-01-30 — — US disclosed
US-20190015323-A1 NASAL DRUG PRODUCTS AND METHODS OF THEIR USE Adaph Pharma Limited 2019-01-17 — — US disclosed
US-20170071851-A1 NASAL DRUG PRODUCTS AND METHODS OF THEIR USE INDIVIOR UK LIMITED (GB) 2017-03-16 — — US disclosed
US-20170071851-A1 NASAL DRUG PRODUCTS AND METHODS OF THEIR USE INDIVIOR UK LIMITED (GB) 2017-03-16 — — US disclosed
WO-2014153099-A2 METHOD FOR USING EXHALED BREATH TO DETERMINE THE PRESENCE OF DRUG Pulmonary Analytics (US) 2014-09-25 — — WO disclosed
US-20060252797-A1 Receptor regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-11-09 — — US disclosed
EP-1559428-A1 RECEPTOR REGULATOR Takeda Pharmaceutical Company Limited (JP) 2005-08-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170071851-A1 NASAL DRUG PRODUCTS AND METHODS OF THEIR USE OPRL1, OPRM1, OPRK1 OPRM1 2/4885SIGMAR1 6/4885CHRM3 129/4885
US-20210093557-A1 NASAL DRUG PRODUCTS AND METHODS OF THEIR USE OPRL1, OPRM1, OPRK1 OPRM1 2/4885SIGMAR1 6/4885CHRM3 129/4885
US-12529695-B2 Fentanyl analogue detection methods and kits thereof CA13, CA2, CA12 OPRM1 24/4885SIGMAR1 269/4885CHRM3 249/4885
US-20190015323-A1 NASAL DRUG PRODUCTS AND METHODS OF THEIR USE OPRL1, OPRM1, OPRK1 OPRM1 2/4885SIGMAR1 6/4885CHRM3 129/4885
US-20200030229-A1 NASAL DRUG PRODUCTS AND METHODS OF THEIR USE OPRL1, OPRM1, OPRK1 OPRM1 2/4885SIGMAR1 6/4885CHRM3 129/4885
US-20060252797-A1 Receptor regulator NMUR1, NMUR2, NMBR OPRM1 148/4885SIGMAR1 179/4885CHRM3 364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.